These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12904144)

  • 1. Anticoagulant-related skin reactions.
    Jörg I; Fenyvesi T; Harenberg J
    Expert Opin Drug Saf; 2002 Sep; 1(3):287-94. PubMed ID: 12904144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous reactions to anticoagulants. Recognition and management.
    Harenberg J; Hoffmann U; Huhle G; Winkler M; Bayerl C
    Am J Clin Dermatol; 2001; 2(2):69-75. PubMed ID: 11705306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux.
    Koch P
    Contact Dermatitis; 2003 Dec; 49(6):276-80. PubMed ID: 15025697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complex clinical picture of side effects to anticoagulation.
    Trautmann A; Seitz CS
    Med Clin North Am; 2010 Jul; 94(4):821-34, xii-iii. PubMed ID: 20609865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides.
    Ludwig RJ; Schindewolf M; Alban S; Kaufmann R; Lindhoff-Last E; Boehncke WH
    Thromb Haemost; 2005 Dec; 94(6):1265-9. PubMed ID: 16411404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergy to heparins and anticoagulants with a similar pharmacological profile: an update.
    Jappe U
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):605-13. PubMed ID: 17102645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of 19 cases of allergy to heparins with positive skin testing].
    Phan C; Vial-Dupuy A; Autegarden JE; Amsler E; Gaouar H; Abuaf N; Pecquet C; Francès C; Soria A
    Ann Dermatol Venereol; 2014 Jan; 141(1):23-9. PubMed ID: 24461090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Hirsh J; Bauer KA; Donati MB; Gould M; Samama MM; Weitz JI
    Chest; 2008 Jun; 133(6 Suppl):141S-159S. PubMed ID: 18574264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of heparin-induced skin lesions, intracutaneous tests, and heparin-induced IgG.
    Harenberg J; Huhle G; Wang L; Hoffmann U; Bayerl C; Kerowgan M
    Allergy; 1999 May; 54(5):473-7. PubMed ID: 10380778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins: tolerance of a new recombinant hirudin.
    Koch P; Münssinger T; Rupp-John C; Uhl K
    J Am Acad Dermatol; 2000 Apr; 42(4):612-9. PubMed ID: 10727306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eczematous plaques related to unfractionated and low-molecular-weight heparins: cross-reaction with danaparoid but not with desirudin.
    Martin L; Machet L; Gironet N; Pouplard C; Gruel Y; Vaillant L
    Contact Dermatitis; 2000 May; 42(5):295-6. PubMed ID: 10789857
    [No Abstract]   [Full Text] [Related]  

  • 12. Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases.
    Jappe U; Juschka U; Kuner N; Hausen BM; Krohn K
    Contact Dermatitis; 2004 Aug; 51(2):67-72. PubMed ID: 15373846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two surgical case reports showing atypical heparin-induced thrombocytopenia].
    Höhnke C; Haas S
    Chirurg; 2007 Feb; 78(2):138, 140-1. PubMed ID: 17252251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coumarin-induced skin necrosis following heparin-induced thrombocytopenia and thrombosis. A case report.
    Shahak A; Pósán E; Szücs G; Rigó J; Boda Z
    Angiology; 1996 Jul; 47(7):725-7. PubMed ID: 8686970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study.
    Grassegger A; Fritsch P; Reider N
    Dermatol Surg; 2001 Jan; 27(1):47-52. PubMed ID: 11231243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin and other rapidly acting anticoagulants.
    Hyers TM
    Semin Vasc Surg; 2005 Sep; 18(3):130-3. PubMed ID: 16168887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
    Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Müller MM; Kropff S; Lindhoff-Last E
    J Am Coll Cardiol; 2017 Nov; 70(21):2636-2648. PubMed ID: 29169470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological strategies for inhibition of thrombin activity.
    Alban S
    Curr Pharm Des; 2008; 14(12):1152-75. PubMed ID: 18473863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New anticoagulants: anti IIa vs anti Xa--is one better?
    Bauer KA
    J Thromb Thrombolysis; 2006 Feb; 21(1):67-72. PubMed ID: 16475045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant-induced necrosis of skin and subcutaneous tissues: report of two cases and review of the English literature.
    Renick AM
    South Med J; 1976 Jun; 69(6):775-8, 804. PubMed ID: 779042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.